These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36812723)

  • 1. Prevalence of lymphedema among Anderson-Fabry disease patients: A report from the Fabry registry.
    Alkhatib D; Vega JA; Pour-Ghaz I; Al-Taweel O; Khan S; DeCarr K; Bath A; Rawal A; Wilbanks D; Raja J; Butt A; Yedlapati N; Hopkin RJ; Jefferies JL
    Mol Genet Metab; 2023 Apr; 138(4):107538. PubMed ID: 36812723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Differences in Anderson-Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women.
    Faro DC; Losi V; Rodolico MS; Torrisi EM; Colomba P; Duro G; Monte IP
    Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment.
    Putko BN; Wen K; Thompson RB; Mullen J; Shanks M; Yogasundaram H; Sergi C; Oudit GY
    Heart Fail Rev; 2015 Mar; 20(2):179-91. PubMed ID: 25030479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic Expression and Outcomes in Patients with the p.Arg301Gln
    Blanco R; Rico-Ramírez Y; Hermida-Ameijeiras Á; Abdullah IMS; Lau K; Alvarez-Rubio J; Fortuny E; Martínez-Monzonís A; Nowak A; Nordbeck P; Veras-Burgos C; Pons-Llinares J; Rossi E; Caimi-Martínez F; Bosch-Rovira T; Alamar-Cervera M; Ruiz-Pizarro V; Torres-Juan L; Heine-Suñer D; Ripoll-Vera T
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurological complications of Anderson-Fabry disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Arnao V; Licata G; Pinto A
    Curr Pharm Des; 2013; 19(33):6014-30. PubMed ID: 23448452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabry disease in patients with migraine with aura.
    Albano B; Dinia L; Del Sette M; Gandolfo C; Sivori G; Finocchi C
    Neurol Sci; 2010 Jun; 31 Suppl 1():S167-9. PubMed ID: 20464614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: An analysis from the Fabry Registry.
    Hopkin RJ; Cabrera GH; Jefferies JL; Yang M; Ponce E; Brand E; Feldt-Rasmussen U; Germain DP; Guffon N; Jovanovic A; Kantola I; Karaa A; Martins AM; Tøndel C; Wilcox WR; Yoo HW; Burlina AP; Mauer M
    Mol Genet Metab; 2023 Feb; 138(2):106967. PubMed ID: 36709533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender-specific plasma proteomic biomarkers in patients with Anderson-Fabry disease.
    Hollander Z; Dai DL; Putko BN; Yogasundaram H; Wilson-McManus JE; Thompson RB; Khan A; West ML; McManus BM; Oudit GY
    Eur J Heart Fail; 2015 Mar; 17(3):291-300. PubMed ID: 25619383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics.
    Favalli V; Disabella E; Molinaro M; Tagliani M; Scarabotto A; Serio A; Grasso M; Narula N; Giorgianni C; Caspani C; Concardi M; Agozzino M; Giordano C; Smirnova A; Kodama T; Giuliani L; Antoniazzi E; Borroni RG; Vassallo C; Mangione F; Scelsi L; Ghio S; Pellegrini C; Zedde M; Fancellu L; Sechi G; Ganau A; Piga S; Colucci A; Concolino D; Di Mascio MT; Toni D; Diomedi M; Rapezzi C; Biagini E; Marini M; Rasura M; Melis M; Nucera A; Guidetti D; Mancuso M; Scoditti U; Cassini P; Narula J; Tavazzi L; Arbustini E
    J Am Coll Cardiol; 2016 Sep; 68(10):1037-50. PubMed ID: 27585509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anderson-Fabry disease: a multiorgan disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
    Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a nationwide screening for Anderson-Fabry disease among dialysis patients.
    Kotanko P; Kramar R; Devrnja D; Paschke E; Voigtländer T; Auinger M; Pagliardini S; Spada M; Demmelbauer K; Lorenz M; Hauser AC; Kofler HJ; Lhotta K; Neyer U; Pronai W; Wallner M; Wieser C; Wiesholzer M; Zodl H; Födinger M; Sunder-Plassmann G
    J Am Soc Nephrol; 2004 May; 15(5):1323-9. PubMed ID: 15100373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical spectrum of Anderson Fabry disease in a Romanian family.
    Tudor A; Muşat A; Doscan A; Bari M; Zapucioiu C; Urdea E; Cochior D; Peţa D
    Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males.
    MacDermot KD; Holmes A; Miners AH
    J Med Genet; 2001 Nov; 38(11):750-60. PubMed ID: 11694547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic substrate of gastropathy in Anderson-Fabry disease.
    Di Toro A; Narula N; Giuliani L; Concardi M; Smirnova A; Favalli V; Urtis M; Alvisi C; Antoniazzi E; Arbustini E
    Orphanet J Rare Dis; 2020 Jun; 15(1):156. PubMed ID: 32571412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry.
    Ortiz A; Cianciaruso B; Cizmarik M; Germain DP; Mignani R; Oliveira JP; Villalobos J; Vujkovac B; Waldek S; Wanner C; Warnock DG
    Nephrol Dial Transplant; 2010 Mar; 25(3):769-75. PubMed ID: 19846394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac manifestations of Anderson-Fabry disease in heterozygous females.
    Kampmann C; Baehner F; Whybra C; Martin C; Wiethoff CM; Ries M; Gal A; Beck M
    J Am Coll Cardiol; 2002 Nov; 40(9):1668-74. PubMed ID: 12427421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabry Disease: prevalence of affected males and heterozygotes with pathogenic
    Doheny D; Srinivasan R; Pagant S; Chen B; Yasuda M; Desnick RJ
    J Med Genet; 2018 Apr; 55(4):261-268. PubMed ID: 29330335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Diversity in Patients with Anderson-fabry Disease with the R301Q Mutation.
    Yamamoto S; Nagasawa T; Sugimura K; Kanno A; Tatebe S; Aoki T; Sato H; Kozu K; Konno R; Nochioka K; Satoh K; Shimokawa H
    Intern Med; 2019 Feb; 58(4):603-607. PubMed ID: 30333391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-risk screening for Anderson-Fabry disease in patients with cardiac, renal, or neurological manifestations.
    Nakagawa N; Sawada J; Sakamoto N; Takeuchi T; Takahashi F; Maruyama JI; Momosaki K; Nakamura K; Endo F; Hasebe N
    J Hum Genet; 2019 Sep; 64(9):891-898. PubMed ID: 31213654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of the respiratory involvement in Anderson-Fabry disease.
    Magage S; Lubanda JC; Susa Z; Bultas J; Karetová D; Dobrovolný R; Hrebícek M; Germain DP; Linhart A
    J Inherit Metab Dis; 2007 Oct; 30(5):790-9. PubMed ID: 17619837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.